Harkin-Enzi Statement on House Passage of Bipartisan FDA User Fee Legislation
Wednesday, June 20, 2012
WASHINGTON, D.C. – Senate Health, Education, Labor and Pensions Committee Chairman Tom Harkin (D-Iowa) and Ranking Member Mike Enzi (R-Wyo.) today released the following statement after the House of Representatives passed the bipartisan Food and Drug Administration Safety and Innovation Act (S.3187), which would reauthorize the user fee programs for the Food and Drug Administration:
“We are pleased to see the House pass this important legislation, which will help patients, create jobs and save lives. This bipartisan bill shows what Congress can accomplish when we focus on the important work of the American people. We look forward to Senate passage next week and then sending a bill to the President for his signature.”
# # #
Recent News
- Harkin Statement on House Vote That Would Make College More Expensive for Millions of American Students [Chairman]
- Harkin Reintroduces FIT Kids Act to Combat Childhood Obesity and Promote Physical Activity [Chairman]
- Alexander Opposes Nominees to NLRB Who Remained on Board After Court Found Their Appointments Unconstitutional [Ranking Member]
- Senate Health Committee Passes Alexander and Colleagues’ Bill to Fix Responsibility for Safety of Sterile Compounded Drugs [Ranking Member]
- Harkin Statement on HELP Committee Approval of a Full Slate of Five Nominees to the NLRB [Chairman]
- Harkin Statement on HELP Committee Passage of the Pharmaceutical Compounding Quality and Accountability Act and the Drug Supply Chain Security Act [Chairman]
